亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels

医学 内科学 危险系数 胰腺癌 胃肠病学 比例危险模型 中性粒细胞与淋巴细胞比率 肿瘤科 癌症 胆红素 淋巴结 置信区间 总体生存率
作者
M. Hosein Aziz,Kostandinos Sideras,Nasir Ahmad Aziz,Katya Mauff,Roel Haen,Daphne Roos,Lawlaw Saida,Mustafa Suker,Erwin van der Harst,Jan Sven David Mieog,Bert A. Bonsing,Yarne Klaver,Bas Groot Koerkamp,Casper H.J. van Eijck
出处
期刊:Annals of Surgery [Lippincott Williams & Wilkins]
卷期号:270 (1): 139-146 被引量:261
标识
DOI:10.1097/sla.0000000000002660
摘要

OBJECTIVE: Our aim was to determine the prognostic significance of the systemic-immune-inflammation index (SIII) in patients with resectable pancreatic cancer, using cancer-specific survival as the primary outcome. BACKGROUND: Pancreatic cancer is associated with a dysfunctional immune system and poor prognosis. We examined the prognostic significance of the SIII in patients with resectable pancreatic ductal adenocarcinoma (PDAC) and the effects of bilirubin on this index. METHODS: We retrospectively assessed all pancreatic resections performed between 2004 and 2015 at 4 tertiary referral centers to identify pathologically confirmed PDAC patients. Baseline clinicopathologic characteristics, preoperative laboratory values such as absolute neutrophil, lymphocyte, and platelet counts, C-reactive protein, albumin, bilirubin, and CA19-9 levels, and also follow-up information, were collected. The associations of the calculated inflammatory indices with outcome were both internally and externally validated. RESULTS: In all, 590 patients with resectable PDAC were included. The discovery and validation cohort included 170 and 420 patients, respectively. SIII >900 [hazard ratio (HR) 2.32, 95% confidence interval (CI) 1.55-3.48], lymph node ratio (HR 3.75, 95% CI 2.08-6.76), and CA19.9 >200 kU/L (HR 1.62, 95% CI 1.07-2.46) were identified as independent predictors of cancer-specific survival. Separate model analysis confirmed that preoperative SIII contributed significantly to prognostication. However, SIII appeared to lose its prognostic significance in patients with bilirubin levels above 200 μmol/L. CONCLUSIONS: SIII is an independent predictor of cancer-specific survival and recurrence in patients with resectable PDAC. SIII may lose its prognostic significance in patients with high bilirubin levels. Properly designed prospective studies are needed to further confirm this hypothesis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
真实的瑾瑜完成签到 ,获得积分10
3秒前
hilape完成签到,获得积分10
3秒前
cc完成签到,获得积分10
5秒前
李健应助xuan采纳,获得10
6秒前
helloWorld完成签到,获得积分10
7秒前
完美世界应助昏睡的芒果采纳,获得10
9秒前
10秒前
乐乐应助xuan采纳,获得10
26秒前
菜园子发布了新的文献求助10
40秒前
幸福丹蝶完成签到,获得积分10
41秒前
molihuakai应助xuan采纳,获得30
47秒前
50秒前
54秒前
曲聋五完成签到 ,获得积分0
59秒前
学术混子完成签到,获得积分10
1分钟前
科研通AI6.2应助xuan采纳,获得10
1分钟前
1分钟前
RJ发布了新的文献求助10
1分钟前
科研通AI6.4应助正直的箴采纳,获得10
1分钟前
李健应助科研通管家采纳,获得10
1分钟前
jimmy_bytheway完成签到,获得积分0
1分钟前
1分钟前
CipherSage应助xuan采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
复杂芷文完成签到,获得积分10
1分钟前
可爱的函函应助xuan采纳,获得10
1分钟前
1分钟前
1分钟前
hilape发布了新的文献求助10
2分钟前
牢大完成签到 ,获得积分10
2分钟前
2分钟前
科研通AI6.4应助xuan采纳,获得10
2分钟前
正直的箴发布了新的文献求助10
2分钟前
热情的衬衫完成签到,获得积分10
2分钟前
2分钟前
ZOE应助Nusha采纳,获得30
2分钟前
aa完成签到,获得积分10
2分钟前
奋斗不二完成签到,获得积分10
3分钟前
高分求助中
Markov Chain Monte Carlo 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Common Foundations of American and East Asian Modernisation: From Alexander Hamilton to Junichero Koizumi 5000
Pediatric Dermoscopy Trichoscopy & Onychoscopy 2030
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
Discerning Saints: Moralization of Intrinsic Motivation and Selective Prosociality at Work 500
Handbuch Trainingswissenschaft – Trainingslehre 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7578408
求助须知:如何正确求助?哪些是违规求助? 9158041
关于积分的说明 19592585
捐赠科研通 7161824
什么是DOI,文献DOI怎么找? 3265547
关于科研通互助平台的介绍 2430497
邀请新用户注册赠送积分活动 2256268